References
Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker D, Doll J, Mäcke H, Hofmann M, Debus J, Haberkorn U. PET imaging of somatostatin receptors using [68Ga]-DOTA-d Phe1-Tyr3-octreotide (DOTATOC): first results in meningioma patients. J Nucl Med 2001; 42:1053–1056.
HofmannM, MaeckeH, Börner AR, Weckesser E, Schöffski P, Oei ML, Schumacher J, Henze M, Heppeler A, Meyer GJ, Knapp WH. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001; 28:1751–1757.
Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using68Ga-DOTA-d Phe(1)-Tyr(3)-octreotide in comparison to 111In-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003; 5:42–48.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henze, M., Schuhmacher, J., Dimitrakopoulou-Strauss, A. et al. Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with 68Ga-DOTATOC PET. Eur J Nucl Med Mol Imaging 31, 466 (2004). https://doi.org/10.1007/s00259-003-1436-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-003-1436-2